Establishment of Human Cellular Disease Models for Morquio Disease
NCT03872713 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2021-04-09
Summary
Establishment of human cellular disease models for Morquio disease for an individualized therapy development having the capacity to address both hepatic and neurologic forms of the disease
Conditions
- Morquio Disease
Sponsors & Collaborators
-
CENTOGENE GmbH Rostock
lead INDUSTRY
Principal Investigators
-
Arndt Rolfs, Prof. Dr. · CENTOGENE GmbH Rostock
Eligibility
- Min Age
- 12 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-10-26
- Primary Completion
- 2019-12-01
- Completion
- 2019-12-01
Countries
- Pakistan
Study Locations
More Related Trials
-
Umbilical Cord Mesenchymal Stem Cells for Patients With Liver Cirrhosis
NCT01220492 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Liver MSCs in Blood of Patients With Liver Disease.
NCT03632148 ·Status: COMPLETED
-
Safety and Efficacy of Mesenchymal Stem Cell Transplantation for Acute-on-Chronic Liver Failure
NCT03863002 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLD
NCT05644717 ·Status: RECRUITING ·Phase: PHASE4
-
Clinical Trial of Umbilical Cord Mesenchymal Stem Cell Transfusion in Decompensated Liver Cirrhosis
NCT03529136 ·Status: UNKNOWN ·Phase: PHASE2
-
Umbilical Cord Mesenchymal Stem Cell Transplantation for Decompensated Hepatitis B Cirrhosis
NCT05106972 ·Status: RECRUITING ·Phase: NA
-
Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis
NCT05121870 ·Status: UNKNOWN ·Phase: PHASE2
-
Resmiterom Efficacy & Safety in Patients With MASH
NCT07249788 ·Status: RECRUITING ·Phase: PHASE4
-
Integrated Approaches for Identifying Molecular Targets in Liver Disease
NCT03915002 ·Status: COMPLETED
-
Effect of Different Dosage of Umbilical Cord-mesenchymal Stem Cells Through Peripheral Vein in Patients With ESLD
NCT06167473 ·Status: COMPLETED ·Phase: NA
-
Umbilical Cord Mesenchymal Stem Cells for Patients With Primary Biliary Cirrhosis
NCT01662973 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Clinical Trial Study About Human Adipose-Derived Stem Cells in the Liver Cirrhosis
NCT02297867 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study of Umbilical Mesenchymal Stem Cells for Liver Cirrhosis
NCT01573923 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-1b)
NCT05984303 ·Status: UNKNOWN ·Phase: PHASE1
-
Efficacy of Plasmapheresis in Patients of Drug-Induced Liver Injury (DILI) With Underlying Chronic Liver Disease
NCT06797011 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF
NCT01937130 ·Status: TERMINATED ·Phase: PHASE2
-
Mesenchymal Stem Cell Transplantation in Decompensated Cirrhosis
NCT00476060 ·Status: COMPLETED ·Phase: PHASE2
-
Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver
NCT02273362 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of Human Umbilical Cord Derived Mesenchymal Stem Cells for Treatment of HBV-related Liver Cirrhosis
NCT01728727 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of Pentoxifylline in Improving Oxygenation in Hepatopulmonary Syndrome
NCT05373134 ·Status: UNKNOWN ·Phase: NA
-
Combination of Autologous MSC and HSC Infusion in Patients With Decompensated Cirrhosis
NCT04243681 ·Status: COMPLETED ·Phase: PHASE4
-
An Follow-Up Study of Liver Cirrhosis
NCT03472742 ·Status: COMPLETED
-
Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2)
NCT05224960 ·Status: RECRUITING ·Phase: PHASE2
-
Tissue Models for Liver Disease
NCT05255042 ·Status: COMPLETED
-
Human Fetal Liver Cell Transplantation in Chronic Liver Failure
NCT01013194 ·Status: COMPLETED ·Phase: PHASE1/PHASE2